// App-Quantinova.ai

AB0580 : A PROSPECTIVE OPEN-LABEL SINGLE CENTER STUDY OF ADALIMUMAB IN BEHCET ARTHRITIS

Researchers

Presenter

  • Y. Braun-Moscovici

Principal Investigators

  • Y. Tavor

  • D. Markovits

  • M. Naffaa

  • K. Toledano

  • A. Rozin

  • R. Beshara-Garzoz

  • M.A. Nahir

  • A. Balbir-Gurman

Medical Centers

  • B. Shine Rheumatology Unit, Rambam Health Care Campus, Rappaport Faculty of Medicine, Technion - Institute of Technology, Haifa, Israel

Locations

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Ophthalmology (OP)

Disease

  • Deep vein thrombosis

  • Behcet disease

  • Erythema nodosum leprosum

  • Venous thrombosis

  • Inflammatory Arthritis

  • Uveitis

Biomarkers

  • C reactive protein

  • Estrogen receptor alpha

Drug/Treatment

  • Adalimumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved